BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24900104)

  • 1. Dynamic (18) F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts.
    Kristian A; Nilsen LB; Røe K; Revheim ME; Engebråten O; Mælandsmo GM; Holm R; Malinen E; Seierstad T
    Nucl Med Mol Imaging; 2013 Sep; 47(3):173-80. PubMed ID: 24900104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic 2-Deoxy-2-[
    Kristian A; Holtedahl JE; Torheim T; Futsaether C; Hernes E; Engebraaten O; Mælandsmo GM; Malinen E
    Mol Imaging Biol; 2017 Apr; 19(2):271-279. PubMed ID: 27541026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influx rate of
    Pitman KE; Alluri SR; Kristian A; Aarnes EK; Lyng H; Riss PJ; Malinen E
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2190-2198. PubMed ID: 31264167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography and pharmacokinetics of 2-[18F]-fluoroethyl choline for metabolic studies in breast cancer xenografts.
    Kristian A; Riss P; Qu H; Milde M; Schoultz BW; Engebraaten O; Mælandsmo GM; Malinen E
    Acta Oncol; 2014 Aug; 53(8):1086-92. PubMed ID: 25017377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
    Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML
    Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts.
    Kristian A; Revheim ME; Qu H; Mælandsmo GM; Engebråten O; Seierstad T; Malinen E
    Acta Oncol; 2013 Oct; 52(7):1566-72. PubMed ID: 23984812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma.
    Kaira K; Endo M; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Tsuya A; Nakamura Y; Naito T; Hayashi I; Kondo H; Nakajima T; Yamamoto N
    Lung Cancer; 2011 Feb; 71(2):144-50. PubMed ID: 20646779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.
    Kaira K; Endo M; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Tsuya A; Nakamura Y; Naito T; Hayashi I; Serizawa M; Koh Y; Hanaoka H; Tominaga H; Oriuchi N; Kondo H; Nakajima T; Yamamoto N
    J Clin Oncol; 2010 Aug; 28(23):3746-53. PubMed ID: 20625125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
    Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
    Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Imaging of GLUT1 and GLUT5 in Breast Cancer: A Multitracer Positron Emission Tomography Imaging Study in Mice.
    Wuest M; Hamann I; Bouvet V; Glubrecht D; Marshall A; Trayner B; Soueidan OM; Krys D; Wagner M; Cheeseman C; West F; Wuest F
    Mol Pharmacol; 2018 Feb; 93(2):79-89. PubMed ID: 29142019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.
    Sauter AW; Winterstein S; Spira D; Hetzel J; Schulze M; Mueller M; Pfannenberg C; Claussen CD; Klotz E; Hann von Weyhern C; Horger MS
    J Nucl Med; 2012 Apr; 53(4):521-9. PubMed ID: 22414637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    de Koster EJ; van Engen-van Grunsven ACH; Bussink J; Frielink C; de Geus-Oei LF; Kusters B; Peters H; Oyen WJG; Vriens D;
    Mol Imaging Biol; 2023 Jun; 25(3):483-494. PubMed ID: 36253663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of 18F-FDG accumulation in colorectal cancer cells with mutated KRAS.
    Iwamoto M; Kawada K; Nakamoto Y; Itatani Y; Inamoto S; Toda K; Kimura H; Sasazuki T; Shirasawa S; Okuyama H; Inoue M; Hasegawa S; Togashi K; Sakai Y
    J Nucl Med; 2014 Dec; 55(12):2038-44. PubMed ID: 25453050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.
    Hamann I; Krys D; Glubrecht D; Bouvet V; Marshall A; Vos L; Mackey JR; Wuest M; Wuest F
    FASEB J; 2018 Sep; 32(9):5104-5118. PubMed ID: 29913554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of [18F]FDG uptake and distribution with hypoxia and proliferation in FaDu human squamous cell carcinoma (hSCC) xenografts after single dose irradiation.
    Bruechner K; Bergmann R; Santiago A; Mosch B; Yaromina A; Hessel F; Hofheinz F; van den Hoff J; Baumann M; Beuthien-Baumann B
    Int J Radiat Biol; 2009 Sep; 85(9):772-80. PubMed ID: 19657862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose metabolism gene expression patterns and tumor uptake of ¹⁸F-fluorodeoxyglucose after radiation treatment.
    Wilson GD; Thibodeau BJ; Fortier LE; Pruetz BL; Galoforo S; Baschnagel AM; Chunta J; Oliver Wong CY; Yan D; Marples B; Huang J
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):620-7. PubMed ID: 25304950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
    Huang T; Civelek AC; Li J; Jiang H; Ng CK; Postel GC; Shen B; Li XF
    J Nucl Med; 2012 Aug; 53(8):1262-8. PubMed ID: 22717978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma.
    Thézé B; Bernards N; Beynel A; Bouet S; Kuhnast B; Buvat I; Tavitian B; Boisgard R
    BMC Cancer; 2015 Jul; 15():534. PubMed ID: 26198000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis.
    Røe K; Aleksandersen TB; Kristian A; Nilsen LB; Seierstad T; Qu H; Ree AH; Olsen DR; Malinen E
    Acta Oncol; 2010 Oct; 49(7):914-21. PubMed ID: 20831478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of dynamic
    Sun Y; Xiao L; Wang Y; Liu C; Cao L; Zhai W; Wang B; Yu S; Xin J
    Quant Imaging Med Surg; 2023 Apr; 13(4):2556-2567. PubMed ID: 37064404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.